Literature DB >> 7688888

Opioid hyperexcitability: the application of alternate opioid therapy.

Neil MacDonald1, Linda Der, Sharon Allan, Phillip Champion.   

Abstract

Three cases are reported where patients experienced severe central nervous system adverse effects on high-dose hydromorphone. These effects were rapidly alleviated following a change in therapy to morphine at 20-25% of the usually accepted potency equivalent dose. We recommend caution in using equivalent dose tables when changing opioid therapy in patients receiving high-dose opioid treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688888     DOI: 10.1016/0304-3959(93)90232-E

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

Review 1.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Frequency, Outcomes, and Associated Factors for Opioid-Induced Neurotoxicity in Patients with Advanced Cancer Receiving Opioids in Inpatient Palliative Care.

Authors:  Kyu-Hyoung Lim; Nhu-Nhu Nguyen; Yu Qian; Janet L Williams; Diane D Lui; Eduardo Bruera; Sriram Yennurajalingam
Journal:  J Palliat Med       Date:  2018-09-27       Impact factor: 2.947

3.  The opioid rotation ratio of hydrocodone to strong opioids in cancer patients.

Authors:  Akhila Reddy; Sriram Yennurajalingam; Hem Desai; Suresh Reddy; Maxine de la Cruz; Jimin Wu; Diane Liu; Eden Mae Rodriguez; Jessica Waletich; Seong Hoon Shin; Vicki Gayle; Pritul Patel; Shalini Dalal; Marieberta Vidal; Kimberson Tanco; Joseph Arthur; Kimmie Tallie; Janet Williams; Julio Silvestre; Eduardo Bruera
Journal:  Oncologist       Date:  2014-10-23

4.  Suffering and dying in cancer patients. Research frontiers in controlling confusion, cachexia, and dyspnea.

Authors:  N MacDonald
Journal:  West J Med       Date:  1995-09

5.  Frequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids.

Authors:  Akhila Reddy; Sriram Yennurajalingam; Kalyan Pulivarthi; Shana L Palla; Xuan Wang; Jung Hye Kwon; Susan Frisbee-Hume; Eduardo Bruera
Journal:  Oncologist       Date:  2012-12-13

Review 6.  Opioid analgesics: comparative features and prescribing guidelines.

Authors:  N I Cherny
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

Review 7.  Advances in cancer pain management.

Authors:  F J McDonnell; J W Sloan; S R Hamann
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

Review 8.  Advances in cancer pain management.

Authors:  F J McDonnell; J W Sloan; S R Hamann
Journal:  Curr Pain Headache Rep       Date:  2001-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.